Wells Fargo says AbbVie is undervalued, sees biopharma inventory rallying 36%

May 2, 2022

1 Min Read

admin

AbbVie shares are down 9.7% prior to now month.

TagsAbbvie Inc business news Eli Lilly and Co Investment strategy Markets Pro: Short-term Stock markets

About the author

admin

Add Comment

Click here to post a comment

Cancel reply

Morgan Stanley warns of gaming headwinds and a excessive valuation for Nvidia

Amazon employees will not receives a commission for Covid depart anymore